Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EDDM3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FAM129C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP2C9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DKFZP434L187 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SOX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929681 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALPK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC390705 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHOSPHO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB3IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NSG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MUC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTGDR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on